Oppenheimer analyst Michael Wiederhorn maintains $HCA Healthcare (HCA.US)$ with a buy rating, and adjusts the target price from $390 to $400.
According to TipRanks data, the analyst has a success rate of 66.1% and a total average return of 16.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $HCA Healthcare (HCA.US)$'s main analysts recently are as follows:
The forecast for HCA Healthcare was adjusted with expectations of financial figures falling short of the market consensus, reversing a trend of surpassing projections. This adjustment comes in the wake of disturbances attributed to hurricanes. Despite the recent decline in stock value, there is an anticipation of a potential phase of stabilization.
Despite the challenges posed by the recent hurricanes, HCA Healthcare's Q3 results managed to surpass these adversities. It is anticipated that these effects will persist into Q4, influencing FY2024 guidance towards the lower spectrum. Nevertheless, the company's management forecasts that earnings growth for 2025 will meet or exceed their long-term objectives, supported by an admissions growth trajectory that is projected to exceed the norm by 3%-4%.
After the release of 3Q24 results, expectations from investors were high, yet HCA Healthcare's underlying performance remained strong with same-store revenues increasing by 7.1%, compared to the 7.9% comparative period in the previous year.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
